Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes
Abstract Background Type 2 diabetes mellitus (T2DM) patients exhibit a heightened susceptibility to concurrent hypertension (HTN) and dyslipidemia (DYS), conditions that reciprocally exacerbate cardiovascular risks. This study investigated the association between NF-κB1 polymorphism, related inflamm...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01861-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849332417696890880 |
|---|---|
| author | Chao Zuo Jing Cheng Dongli Yang Yi Liu Hailian Chen Xiang Lu Mengna Guo Zhuo Yang Ziqiang Wang Yu Wang Yongchao Qiao |
| author_facet | Chao Zuo Jing Cheng Dongli Yang Yi Liu Hailian Chen Xiang Lu Mengna Guo Zhuo Yang Ziqiang Wang Yu Wang Yongchao Qiao |
| author_sort | Chao Zuo |
| collection | DOAJ |
| description | Abstract Background Type 2 diabetes mellitus (T2DM) patients exhibit a heightened susceptibility to concurrent hypertension (HTN) and dyslipidemia (DYS), conditions that reciprocally exacerbate cardiovascular risks. This study investigated the association between NF-κB1 polymorphism, related inflammatory mediators, and the predisposition to hypertension and dyslipidemia in T2DM patients, along with their correlations with biochemical parameters. Methods Genotyping of 452 T2DM patients was performed using SNP-scan high-throughput technology. Analyzed polymorphisms encompassed: NF-κB1-rs4648068, upstream transcriptional regulators (TLR2-rs3804099, TLR4-rs2149356, TLR9-rs352140), and downstream inflammatory mediators (IL6-rs1800796, IL6R-rs2228145, IL10-rs1800872, ICAM1-rs5498 and rs3093030). The cohort was stratified into three clinically defined groups: T2DM-only (T2DM group), T2DM with hypertension (T2MH group), and T2DM with comorbid hypertension and dyslipidemia (T2MH-DYS group). The T2MH and T2MH-DYS groups were further subclassified into Grade I-III according to hypertension staging criteria. Plasma biochemical profiles were systematically evaluated to delineate their associations with NF-κB1 pathway genetic variants. Results Patients with T2DM complicated by hypertension (T2MH) or hypertension with dyslipidemia (T2MH-DYS) exhibited distinct metabolic and inflammatory profiles. Genetic analyses revealed significant polymorphisms in inflammatory pathway genes (TLR9, TLR2, NF-κB1, IL6R) across subgroups. TLR9 rs352140 CT heterozygotes conferred a 2.8–2.94-fold increased risk of T2MH/T2MH-DYS, while NF-κB1 rs4648068 GG genotype reduced dyslipidemia risk by 64.8% (P = 0.004). Haplotype analysis identified synergistic effects: the TLR9/IL6R/NF-κB1 risk haplotype (G-C-T) increased hypertension risk 3.26-fold (P = 0.00069), and the IL10/TLR4/NF-κB1 protective haplotype (G-T-A) reduced dyslipidemia risk by 82% (P = 0.0063). IL10 rs1800872 TT genotype and TLR4 rs2149356 G allele were linked to dyslipidemia susceptibility in hypertensive diabetics. Conclusion This study establishes that genetic variants in inflammatory pathways (TLR9, NF-κB1, IL6R) synergistically drive hypertension and dyslipidemia risks in T2DM. |
| format | Article |
| id | doaj-art-d512f45e6ca849ae9a06d9776bcd4942 |
| institution | Kabale University |
| issn | 1758-5996 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Diabetology & Metabolic Syndrome |
| spelling | doaj-art-d512f45e6ca849ae9a06d9776bcd49422025-08-20T03:46:12ZengBMCDiabetology & Metabolic Syndrome1758-59962025-07-0117111710.1186/s13098-025-01861-ySynergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetesChao Zuo0Jing Cheng1Dongli Yang2Yi Liu3Hailian Chen4Xiang Lu5Mengna Guo6Zhuo Yang7Ziqiang Wang8Yu Wang9Yongchao Qiao10Department of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Pathology, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityResearch Center of Clinical Laboratory Science, Bengbu Medical UniversityDepartment of Geriatrics, The First Affiliated Hospital of Guilin Medical UniversityDepartment of Clinical Laboratory, The First Affiliated Hospital of Guilin Medical UniversityAbstract Background Type 2 diabetes mellitus (T2DM) patients exhibit a heightened susceptibility to concurrent hypertension (HTN) and dyslipidemia (DYS), conditions that reciprocally exacerbate cardiovascular risks. This study investigated the association between NF-κB1 polymorphism, related inflammatory mediators, and the predisposition to hypertension and dyslipidemia in T2DM patients, along with their correlations with biochemical parameters. Methods Genotyping of 452 T2DM patients was performed using SNP-scan high-throughput technology. Analyzed polymorphisms encompassed: NF-κB1-rs4648068, upstream transcriptional regulators (TLR2-rs3804099, TLR4-rs2149356, TLR9-rs352140), and downstream inflammatory mediators (IL6-rs1800796, IL6R-rs2228145, IL10-rs1800872, ICAM1-rs5498 and rs3093030). The cohort was stratified into three clinically defined groups: T2DM-only (T2DM group), T2DM with hypertension (T2MH group), and T2DM with comorbid hypertension and dyslipidemia (T2MH-DYS group). The T2MH and T2MH-DYS groups were further subclassified into Grade I-III according to hypertension staging criteria. Plasma biochemical profiles were systematically evaluated to delineate their associations with NF-κB1 pathway genetic variants. Results Patients with T2DM complicated by hypertension (T2MH) or hypertension with dyslipidemia (T2MH-DYS) exhibited distinct metabolic and inflammatory profiles. Genetic analyses revealed significant polymorphisms in inflammatory pathway genes (TLR9, TLR2, NF-κB1, IL6R) across subgroups. TLR9 rs352140 CT heterozygotes conferred a 2.8–2.94-fold increased risk of T2MH/T2MH-DYS, while NF-κB1 rs4648068 GG genotype reduced dyslipidemia risk by 64.8% (P = 0.004). Haplotype analysis identified synergistic effects: the TLR9/IL6R/NF-κB1 risk haplotype (G-C-T) increased hypertension risk 3.26-fold (P = 0.00069), and the IL10/TLR4/NF-κB1 protective haplotype (G-T-A) reduced dyslipidemia risk by 82% (P = 0.0063). IL10 rs1800872 TT genotype and TLR4 rs2149356 G allele were linked to dyslipidemia susceptibility in hypertensive diabetics. Conclusion This study establishes that genetic variants in inflammatory pathways (TLR9, NF-κB1, IL6R) synergistically drive hypertension and dyslipidemia risks in T2DM.https://doi.org/10.1186/s13098-025-01861-yNF-κB1PolymorphismT2DMHypertension classificationDyslipidemia |
| spellingShingle | Chao Zuo Jing Cheng Dongli Yang Yi Liu Hailian Chen Xiang Lu Mengna Guo Zhuo Yang Ziqiang Wang Yu Wang Yongchao Qiao Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes Diabetology & Metabolic Syndrome NF-κB1 Polymorphism T2DM Hypertension classification Dyslipidemia |
| title | Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes |
| title_full | Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes |
| title_fullStr | Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes |
| title_full_unstemmed | Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes |
| title_short | Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes |
| title_sort | synergistic effects of nf κb1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes |
| topic | NF-κB1 Polymorphism T2DM Hypertension classification Dyslipidemia |
| url | https://doi.org/10.1186/s13098-025-01861-y |
| work_keys_str_mv | AT chaozuo synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT jingcheng synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT dongliyang synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT yiliu synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT hailianchen synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT xianglu synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT mengnaguo synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT zhuoyang synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT ziqiangwang synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT yuwang synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes AT yongchaoqiao synergisticeffectsofnfkb1andinflammatorypathwaypolymorphismsonhypertensionanddyslipidemiasusceptibilityintype2diabetes |